Liver Transplantation for Malignant Tumours in Children

Abstract

Objective: The object of this study was to analyse our results with liver transplantation (LTX) for primitive malignant unresectable liver tumours in children and to discuss the controversial indications, based on our experience. Methods/Patients: We report on 12 patients, aged 6 months to 14 years, with hepatic malignant tumours: 11 with hepatoblastoma and 1 with fibrolamellar hepatocelullar carcinoma without cirrhosis. LTX was the primary treatment in 10 patients (PRETEXT IV or any grade, if there was extension to the retrohepatic vena cava, 3 hepatic veins or portal vein) and a rescue therapy after recurrence for 1 and for persistence of unresectable macroscopic residuals in 2 patients. One of the patients who underwent a LTX as primary therapy had lung metastases previously resolved with chemotherapy. We used entire liver (n = 5), left lateral segment from cadaveric donor (n = 3), living related donor (n = 3; 2 segments II - III and 1 right lobe) and left lateral segment from split liver (n = 1). All children received chemotherapy prior and post transplantation following the SIOPEL protocol. We analysed procedure tolerance, survival, recurrence rate, disease-free period and risk factors for adverse evolution. Results: All patients overcame LTX and no early graft loss was recorded. Two cases died because of tumour relapse, 1 after primary LTX and 1 after rescue LTX (survival rate of both groups, 90 % and 50 %). Graft and patient survival rates at 1 year, 3 years, 5 years and 14 years were 91 %, 91 %, 82 % and 82 % respectively. The boy who presented with lung metastases developed new ones one year after LTX that were removed and he is currently free of disease. The disease-free period has a probability at 1, 3 and 5 years of 91 %, 75 % and 75 %, respectively. Tumour tissue persistence was the only risk factor for an adverse clinical course in our series. Conclusions: LTX is a reasonable therapeutic approach for unresectable malignant liver tumours, providing outcomes comparable to those for resectable tumours. Results obtained with LTX are better when it is used as a primary treatment than when used as a rescue procedure. Proper staging and early referral to centres with enough expertise optimise the results. LTX for patients with lung metastases could be a controversial option. Living related-donor transplantation is an excellent alternative to avoid disease progression while on the waiting list for cadaveric donors.

Key words

Hepatoblastoma - liver transplantation - liver tumours - children

References

• 1 Achilleos O A, Buist L J, Kelly D A, Raafat F, McMaster P, Mayer A D, Buckels J A. Unresectable hepatic tumors in childhood and the role of liver transplantation.  J Pediatr Surg. 1996;  31 1563-1567
• 2 Chardot C, Saint Martin C, Gilles A, Brichard B, Janssen M, Sokal E, Clapuyt P, Lerut J, Reding R, Otte J B. Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma.  Transplantation. 2002;  73 90-92
• 3 DeBaun M R, Tucker M A. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.  J Pediatr. 1998;  132 398-400
• 4 Douglass E C. Hepatic malignancies in childhood and adolescence (hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma).  Cancer Treat Res. 1997;  92 201-212
• 5 Dower N A, Smith L J, Lees G, Kneteman N, Idikio H, Emond J, Rosenthal P. Experience with aggressive therapy in three children with unresectable malignant liver tumors.  Med Pediatr Oncol. 2000;  34 132-135
• 6 Exelby P R, Filler R M, Grosfeld J L. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey.  J Pediatr Surg. 1975;  10 329-337
• 7 Feusner J, Plaschkes J. Hepatoblastoma and low birth weight: a trend or chance observation?.  Med Pediatr Oncol. 2002;  39 508-509
• 8 Feusner J H, Krailo M D, Haas J E, Campbell J R, Lloyd D A, Ablin A R. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Children's Cancer Group.  Cancer. 1993;  71 859-864
• 9 Filler R M, Ehrlich P F, Greenberg M L, Babyn P S. Preoperative chemotherapy in hepatoblastoma.  Surgery. 1991;  110 591-596
• 10 Garber J E, Li F P, Kingston J E, Krush A J, Strong L C, Finegold M J, Bertario L, Bulow S, Filippone Jr A, Gedde-Dahl Jr T. et al . Hepatoblastoma and familial adenomatous polyposis.  J Natl Cancer Inst. 1988;  80 1626-1628
• 11 Giardiello F M, Offerhaus G J, Krush A J, Booker S V, Tersmette A C, Mulder J W, Kelley C N, Hamilton S R. Risk of hepatoblastoma in familial adenomatous polyposis.  J Pediatr. 1991;  119 766-768
• 12 Gruner B A, DeNapoli T S, Andrews W, Tomlinson G, Bowman L, Weitman S D. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis.  J Pediatr Hematol Oncol. 1998;  20 274-278
• 13 Hemming A W, Reed A I, Langham M R, Fujita S, van der Werf W J, Howard R J. Hepatic vein reconstruction for resection of hepatic tumors.  Ann Surg. 2002;  235 850-858
• 14 Hughes L J, Michels V V. Risk of hepatoblastoma in familial adenomatous polyposis.  Am J Med Genet. 1992;  43 1023-1025
• 15 Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: a trend or a chance?.  J Pediatr. 1997;  130 557-560
• 16 Kapfer S A, Petruzzi M J, Caty M G. Hepatoblastoma in low birth weight infants: an institutional review.  Pediatr Surg Int. 2004;  20 753-756
• 17 King D R, Ortega J, Campbell J, Haas J, Ablin A, Lloyd D, Newman K, Quinn J, Krailo M, Feusner J. et al . The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy.  J Pediatr Surg. 1991;  26 1074-1080
• 18 Koneru B, Flye M W, Busuttil R W, Shaw B W, Lorber M I, Emond J C, Kalayoglu M, Freese D K, Starzl T E. Liver transplantation for hepatoblastoma. The American experience.  Ann Surg. 1991;  213 118-121
• 19 Lockwood L, Heney D, Giles G R, Lewis I J, Bailey C C. Cisplatin-resistant metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplantation.  Med Pediatr Oncol. 1993;  21 517-520
• 20 Mann J R, Kasthuri N, Raafat F, Pincott J R, Parkes S E, Muir K R, Ingram L C, Cameron A H. Malignant hepatic tumours in children: incidence, clinical features and aetiology.  Paediatr Perinat Epidemiol. 1990;  4 276-289
• 21 Martinez L, Lopez-Santamaría M, Gamez M, Murcia J, Tovar J A. Tumores primitivos del hígado en niños: analísis de 62 casos consecutivos.  Cir Pediatr. 2000;  13 110-115
• 22 Ninane J, Perilongo G, Stalens J P, Guglielmi M, Otte J B, Mancini A. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study.  Med Pediatr Oncol. 1991;  19 199-203
• 23 Ortega J A, Krailo M D, Haas J E, King D R, Ablin A R, Quinn J J, Feusner J, Campbell J R, Lloyd D A, Cherlow J. et al . Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Children's Cancer Study Group.  J Clin Oncol. 1991;  9 2167-2176
• 24 Otte J B, Aronson D, Vraux H, de Ville de Goyet J, Reding R, Ninane J, Clapuyt P, Veyckemans F, Van Obbergh L, Gosseye S. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children.  Transplant Proc. 1996;  28 2393-2394
• 25 Otte J B, de Ville de Goyet J, Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era.  Pediatr Transplant. 2005;  9 557-565
• 26 Otte J B, Pritchard J, Aronson D C, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL‐1 and review of the world experience.  Pediatr Blood Cancer. 2004;  42 74-83
• 28 Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte J B, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2.  Eur J Cancer. 2004;  40 411-421
• 29 Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma.  Lancet Oncol. 2000;  1 94-100
• 30 Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology.  J Clin Oncol. 2000;  18 3819-3828
• 31 Rela M, Vougas V, Muiesan P, Smyrniotis V, Gibbs P, Williams R, Heaton N D. Split liver transplantation: a way forward?.  Transplant Proc. 1997;  29 562-563
• 32 Reyes J D, Carr B, Dvorchik I, Kocoshis S, Jaffe R, Gerber D, Mazariegos G V, Bueno J, Selby R. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence.  J Pediatr. 2000;  136 795-804
• 33 Reynolds M, Douglass E C, Finegold M, Cantor A, Glicksman A. Chemotherapy can convert unresectable hepatoblastoma.  J Pediatr Surg. 1992;  27 1080-1083
• 34 Saxena R, Leake J L, Shafford E A, Davenport M, Mowat A P, Pritchard J, Mieli-Vergani G, Howard E R, Spitz L, Malone M. et al . Chemotherapy effects on hepatoblastoma. A histological study.  Am J Surg Pathol. 1993;  17 1266-1271
• 35 Schnater J M, Aronson D C, Plaschkes J, Perilongo G, Brown J, Otte J B, Brugieres L, Czauderna P, MacKinlay G, Vos A. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.  Cancer. 2002;  94 1111-1120
• 36 Shafford E A, Pritchard J. Hepatoblastoma - a bit of a success story?.  Eur J Cancer. 1994;  30 A 1050-1051
• 37 Srinivasan P, McCall J, Pritchard J, Dhawan A, Baker A, Vergani G M, Muiesan P, Rela M, David Heaton N. Orthotopic liver transplantation for unresectable hepatoblastoma.  Transplantation. 2002;  74 652-655